US Apex court decisions show that patent concerns are misplaced: IPA

Source: The Indian Express

27 Jan 2015

As US companies raise concerns about India’s pharma sector and the country’s “deteriorating” intellectual property rights (IPR) regime, an Indian industry lobby has refuted the claims and pointed out that the IP regime, “even in the US is litigious and more unpredictable than India”, as evident by the decisions taken by its Supreme Court.

The Indian Pharmaceutical Alliance (IPA), in a note furnished to corporates participating in the India-US CEO forum and the government, has said that country’s intellectual patent regime conforms to the WTO norms and “they are using the US regime as benchmark to evaluate India’s intellectual patent regime. But India has never agreed to conform to the United States standards… accepted international standards as embodied in the Trade Related Aspects of Intellectual Property Rights (TRIPs) 1994 Agreement… these concerns are misplaced.”


This entry was posted in Compulsory Licensing, TRIPS, US pressure on India. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s